Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Health Policy (Amsterdam, Netherlands)
|
August 2, 2011
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010
Sylvain Pichetti, Christine Sorasith, Catherine Sermet
Community Mental Health Journal
|
December 21, 2013
Factors influencing report of common mental health problems among psychologically distressed adults
Myriam Khlat, Stéphane Legleye, Catherine Sermet
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 16, 2014
Entry time effects and follow-on drug competition
Luiz Flavio Andrade, Catherine Sermet, Sylvain Pichetti
European Journal of Epidemiology
|
July 6, 2004
Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France
Myriam Khlat, Catherine Sermet, Annick Le Pape
European Journal of Clinical Pharmacology
|
June 12, 2017
Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population
Marie Herr, Nicolas Sirven, Hélène Grondin, et al.
Presse Medicale (Paris, France : 1983)
|
March 3, 2007
[Cost of obesity in France]
Corinne Emery, Jérôme Dinet, Antoine Lafuma, et al.
Applied Health Economics and Health Policy
|
April 24, 2013
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France
Sylvain Pichetti, Catherine Sermet, Brian Godman, et al.
The Journal of Antimicrobial Chemotherapy
|
July 10, 2004
No significant decrease in antibiotic use from 1992 to 2000, in the French community
Agnès Sommet, Catherine Sermet, Pierre Yves Boëlle, et al.
Applied Health Economics and Health Policy
|
December 30, 2009
Ongoing pharmaceutical reforms in France: implications for key stakeholder groups
Catherine Sermet, Veronique Andrieu, Brian Godman, et al.
Joint Bone Spine
|
June 9, 2004
Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy
Stéphane Bouée, Agnès Charlemagne, Francis Fagnani, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Health Policy (Amsterdam, Netherlands)
|
August 2, 2011
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010
Sylvain Pichetti, Christine Sorasith, Catherine Sermet
Community Mental Health Journal
|
December 21, 2013
Factors influencing report of common mental health problems among psychologically distressed adults
Myriam Khlat, Stéphane Legleye, Catherine Sermet
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 16, 2014
Entry time effects and follow-on drug competition
Luiz Flavio Andrade, Catherine Sermet, Sylvain Pichetti
European Journal of Epidemiology
|
July 6, 2004
Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France
Myriam Khlat, Catherine Sermet, Annick Le Pape
European Journal of Clinical Pharmacology
|
June 12, 2017
Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population
Marie Herr, Nicolas Sirven, Hélène Grondin, et al.
Presse Medicale (Paris, France : 1983)
|
March 3, 2007
[Cost of obesity in France]
Corinne Emery, Jérôme Dinet, Antoine Lafuma, et al.
Applied Health Economics and Health Policy
|
April 24, 2013
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France
Sylvain Pichetti, Catherine Sermet, Brian Godman, et al.
The Journal of Antimicrobial Chemotherapy
|
July 10, 2004
No significant decrease in antibiotic use from 1992 to 2000, in the French community
Agnès Sommet, Catherine Sermet, Pierre Yves Boëlle, et al.
Applied Health Economics and Health Policy
|
December 30, 2009
Ongoing pharmaceutical reforms in France: implications for key stakeholder groups
Catherine Sermet, Veronique Andrieu, Brian Godman, et al.
Joint Bone Spine
|
June 9, 2004
Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy
Stéphane Bouée, Agnès Charlemagne, Francis Fagnani, et al.
Page
of 3